Skip to content

Clinical trials

Phase 2 Cerebral Hemorrhage trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cerebral Hemorrhage Phase: Phase 2 Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20041
20051
20081
20093
20102
20121
20132
20141
20172
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated6
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johns Hopkins University3
Beth Israel Deaconess Medical Center2
AegisCN LLC1
AstraZeneca1
Daniel Hanley1
Georgetown University1
Henry Ford Health System1
Northwestern University1
Novartis Pharmaceuticals1
Novo Nordisk A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cerebral Hemorrhage19
Stroke3
Hemorrhage2
Intracranial Hemorrhages2
Ischemic Stroke2
Subarachnoid Hemorrhage2
Brain Edema1
Cataplexy1
Edema1
Hemorrhagic Stroke1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.